TipRanks
Go Ultimate75% OFF

Naturewise Biotech & Medicals Corporation (4732) Stock Price & Analysis

4732 Stock Chart & Stats

NT$14.80-NT$0.75(-4.82%)
At close: 12:09 AM EST
TWD 15TWD 16TWD 17TWD 18Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 14.70 - TWD 14.85
52-Week Range
TWD 14.70 - TWD 24.60
Previous Close
TWD 15.55
Volume
N/A
Average Volume (3M)
12.40K
Market Cap
TWD 734.72M
Enterprise Value
N/A
Total Cash (Recent Filing)
TWD 409.13M
Total Debt (Recent Filing)
TWD 31.63M
Price to Earnings (P/E)
―
Beta
0.22
Next Earnings
N/A
EPS Estimate
N/A
Dividend Yield
N/A

4732 FAQ

What was Naturewise Biotech & Medicals Corporation’s price range in the past 12 months?
Naturewise Biotech & Medicals Corporation lowest stock price was TWD 14.70 and its highest was TWD 24.60 in the past 12 months.
What is Naturewise Biotech & Medicals Corporation’s market cap?
Naturewise Biotech & Medicals Corporation’s market cap is TWD 734.72M.
When is Naturewise Biotech & Medicals Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Naturewise Biotech & Medicals Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Naturewise Biotech & Medicals Corporation pay dividends?
Naturewise Biotech & Medicals Corporation pays a ― dividend of TWD 0.2 which represents an annual dividend yield of ―. See more information on Naturewise Biotech & Medicals Corporation dividends here
What is Naturewise Biotech & Medicals Corporation’s EPS estimate?
Naturewise Biotech & Medicals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Naturewise Biotech & Medicals Corporation have?
Naturewise Biotech & Medicals Corporation has 49,643,500 shares outstanding.
Which hedge fund is a major shareholder of Naturewise Biotech & Medicals Corporation?
Currently, no hedge funds are holding shares in TW:4732
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology